Diabetes drug may slow progression of Parkinson’s, say researchers

Researchers say findings that diabetes drug lixisenatide can slow progression of motor symptoms could be exciting step forward

A drug similar to those used in “skinny jabs” could help to slow the progression of symptoms of Parkinson’s disease, research suggests.

According to the Parkinson’s Foundation, more than 10 million people around the world are living with Parkinson’s – a condition in which nerve cells in the brain are lost over time causing problems with movement, balance and memory, among other effects.

Continue reading…

About Author